Answers are grounded in this paper and cite their sources.
In vascular surgical applications, small-diameter vascular grafts made from synthetic polymers are rarely commercialized, owing to delayed reendothelialization and subsequent thrombus formation and occlusion. Here, we describe a novel design for a small-diameter poly-ε-caprolactone (PCL) vascular graft with a functional, bilayered nanofibrous structure and a composition that enables a suitable healing process and gradual degradation/replacement by natural blood vessels. To improve vascular cell responses to the PCL, a natural bioactive polymer (collagen) and a sol–gel-derived bioceramic (silica) were incorporated into the inner and outer layer of the PCL vascular graft, respectively. An electrospinning technique enabled the development of uniform electrospun PCL/collagen and PCL/silica nanofibers. In particular, the orientations of PCL/collagen nanofibers prepared with a high-speed rotating collector were highly aligned, and no breaks or irregular shapes were observed. The thin inner layer, composed of PCL/collagen with longitudinally aligned nanofibers, was favorable for the adhesion, elongation, and migration of endothelial cells, thus eliciting rapid reendothelialization of luminal surfaces of a vascular graft. The relatively thick outer layer, composed of PCL/silica with randomly distributed nanofibers, provided a superior mechanical strength and showed satisfactory biocompatibility. The findings of this study demonstrate a strong potential of PCL-based bilayer vascular grafts for vascular tissue applications.
No takes yet. Share an insight, caveat, or question.
Park et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: